JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
Generic Vial HTRF
| Feature | Specification |
|---|---|
| Application | Protein-Protein Interaction |
Product variants
Unit Size: 5,000 assay points
Part #:
64APPKAA
Unit Size: 20,000 assay points
Part #:
64APPKAB
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
Generic Vial HTRF
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
Product information
Overview
Beta-secretase (BACE1) is an enzyme which cleaves amyloid precursor protein (APP) to produce the amyloid ß42 peptide, responsible for insoluble amyloid plaques in Alzheimer's disease (AD).
APP substrate, used with HTRF APP substrate labeled with both biotin and Eu3+ Cryptate, enables the study of High enzymatic Km to monitor beta-secretase (BACE1) activity.
Specifications
| Application |
Protein-Protein Interaction
|
|---|---|
| Brand |
HTRF
|
| Detection Modality |
HTRF
|
| Product Group |
Fluorescent Reagent
|
| Shipping Conditions |
Shipped in Dry Ice
|
| Target Class |
Binding Assay
|
| Technology |
TR-FRET
|
| Unit Size |
5,000 assay points
|
Video gallery
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
HTRF APP substrate Eu-Conjugate, 5,000 Assay Points
Resources
Are you looking for resources, click on the resource type to explore further.
Brochure
HTRF assays and reagents product list
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
Guide
HTRF solutions, guide to major applications
This guide provides you an overview of HTRF applications in several therapeutic areas.
How can we help you?
We are here to answer your questions.
